Basilea Partners With Glioblastoma Foundation For Lisavanbulin Development
20 Jun 2024 //
GLOBENEWSWIRE
Basilea reports PC data on BAL0891, derazantinib and lisavanbulin at AACR
13 Apr 2022 //
GLOBENEWSWIRE
20 Jun 2024 //
GLOBENEWSWIRE
13 Apr 2022 //
GLOBENEWSWIRE